Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
TWFG $187 million IPO
The shares are listed on the Nasdaq Global Select Market
Banco Santander $3.75 billion notes offering
We advised Banco Santander on its offering of notes
Cleveland-Cliffs $2.5 billion acquisition of Stelco Holdings
We are advising Cleveland-Cliffs on the acquisition
IDEAYA Biosciences $302.5 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Mizuho Financial Group $1.5 billion senior notes offering
The senior callable fixed-to-fixed reset rate notes are due 2030 and 2035
SMFG $4.5 billion senior and subordinated notes offerings
We advised SMFG on its SEC-registered offerings of TLAC notes
Repay Holdings $287.5 million convertible senior notes offering
The 2.875% convertible notes are due 2029
JPMorgan Chase exchange offer for Alerian MLP Index ETNs
We advised JPMorgan Chase in connection with the transaction
Bangkok Bank MTN program update and $750 million notes offering
The investment-grade notes are due 2034
Toronto-Dominion Bank $750 million limited recourse capital notes offering
The 7.25% limited recourse capital notes are due 2084